Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
While CannaKids ceased commercial cannabis sales, research stemming from the company demonstrated that cancer patients treated with cannabinoids showed elevated Natural killer cell function (up to 5x higher than healthy individuals in Sophie Ryan's case). Sophie Ryan's brain tumor showed 85-90% reduction in size following cannabinoid treatment combined with NK cell immunotherapy. Published peer-reviewed findings confirmed cannabinoids activate NK cells and kill cancer stem cells in humanized mouse models
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CannaKids.